Despite nearly three months having passed since the deaths of two patients after they were administered ondansetron, a drug commonly used to treat nausea and vomiting, the Government has still failed to publicise the relevant reports, claimed the Medical and Civil Rights Professional Association of Doctors President, Dr. Chamal Sanjeewa.

Speaking to the media yesterday (11), he said the lack of clarity surrounding the quality and regulatory approval of the relevant drug raises doubts about the safety of medicines being used in State hospitals. He also said the authorities have yet to provide a clear explanation on whether the relevant requirements in India, where the drug was sourced, had been properly verified before procurement and use.

"It is particularly concerning that the issue remains unresolved months after the incident. Two patients lost their lives. The failure to ensure accountability in such cases erodes public confidence in the health system."

He said the regulation and distribution of medicines are currently facing serious challenges due to weaknesses within the relevant institutions. He said these shortcomings have made it difficult to guarantee the quality, safety and proper oversight of pharmaceuticals entering the country.

Dr. Sanjeewa further pointed out that although the Government has announced reductions in the prices of medicines, the State Pharmaceuticals Corporation has failed to procure these medicines at the reduced rates through Government procurement processes. This, he said, has undermined the intended benefits of the price reductions.

He also criticised the Government’s approach to the health sector, noting that despite official claims the country is no longer facing an economic crisis, there has been little attention paid to improving the salaries of middle-class professionals, including doctors. He said this neglect has contributed to dissatisfaction within the medical community.

Deputy Health Minister, Dr. Hansaka Wijemuni was not available for comment.